SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...

A team of researchers from the Indian Institute of Technology (IIT) Madras and Panjab University has developed a portable, ...

Older doesn't necessarily mean better, and with refrigerators, while some things were better in the old days, other things ...

Arrowhead Pharmaceuticals faces key FDA decisions, legal challenges, and trial results. Read the latest analysis on the stock ...

The nineteenth edition of the Dubai International Food Safety Conference, the largest regional platform for global food ...

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.